Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 2,642 | 2,758 | 4,035 | 3,145 | 3,270 |
| Gross Profit | 2,642 | 2,758 | 4,035 | 3,145 | 3,270 |
| Operating Expenses | 1,777 | 1,629 | 1,497 | 1,407 | 1,706 |
| Operating Income | 865 | 1,129 | 2,538 | 1,739 | 1,564 |
| Other Income | 18 | 12 | 44 | 7 | 7 |
| Pre-tax Income | 883 | 1,140 | 2,582 | 1,746 | 1,570 |
| Income Tax | 305 | 386 | 857 | 567 | 542 |
| Net Income Continuous | 578 | 754 | 1,726 | 1,179 | 1,028 |
| Net Income | $578 | $754 | $1,726 | $1,179 | $1,028 |
| EPS Basic Total Ops | 0.09 | 0.12 | 0.27 | 0.19 | 0.16 |
| EPS Basic Continuous Ops | 0.09 | 0.12 | 0.27 | 0.19 | 0.16 |
| EPS Diluted Total Ops | 0.08 | 0.11 | 0.25 | 0.17 | 0.15 |
| EPS Diluted Continuous Ops | 0.08 | 0.11 | 0.25 | 0.17 | 0.15 |
| EBITDA(a) | $929 | $1,173 | $2,554 | $1,755 | $1,580 |